Food Intake Response to Short-Term Modifications of Metabolism in Humans

Energy Intake Response to Short-Term Alterations of Energy Expenditure in Humans

One reason people gain weight is eating more calories from food than what they need for energy over 24 hours. Metabolism is the amount of energy a person uses over 24 hours. Researchers want to study the relationship between changes in metabolism and how much a person eats.

Objectives:

To see how much food a person eats when the body's temperature is cooled. To study how changes in metabolism may alter the amount of food a person eats.

Eligibility:

Healthy people ages 18-55.

Design:

Participants will stay at NIH for 20 days.

During the first 4 days, participants will have:

  • Medical exam
  • Electrocardiogram
  • Blood and urine tests. One blood test includes drinking a sugar solution.
  • DXA body composition scan
  • Questions about foods they like, physical activity, and personal behavior
  • Exercise test on a stationary bicycle

Participants will spend 24-hour periods in a metabolic chamber. The chamber will be at normal room temperature or cooler.

Some times, participants will eat a diet that matches their daily needs (fixed or eucaloric). Other times, they can eat as much as they wish from a vending machine (ad libitum).

Participants will have blood and urine collected.

Participants will swallow an ingestible wireless sensor and wear a small data recorder device.

On the second to last day, participants will stay in the metabolic chamber but only consume water and non-caffeinated sugar-free beverages.

Participants will come back for 1-day visits at six months and one year from the first admission. They will have blood and urine tests, and a DXA scan. They will answer questions on physical activity and food habits.

Study Overview

Detailed Description

More than 30% of adults are considered overweight. In general, lifestyle changes (diet and exercise) or current weight loss drugs only lead to about 5 to 10% weight loss. This may be because a person's energy expenditure, aka the number of calories the body uses, leads to hunger and may increase the amount of food a person eats. Cold exposure is known to increase metabolism but it may not lead to weight loss if appetite and the desire for food are also increased. The primary goal of this study is to evaluate whether changing energy expenditure by cool temperature exposure results in changes in food intake. This study will involve a stay on our clinical research unit where we will determine the energy requirements (at 24 degree C) of 68 healthy, adult volunteers without evidence of diabetes. Exposure to cool temperatures (19 degree C) will be used to increase the number of calories a person's body uses in a day. Participants will spend 24 hours in a room that measures energy expenditure while the temperature in the room is turned down, once with a fixed diet (eucaloric) and once with a buffet of food choices (ad libitum). After the fixed diet, volunteers will self-select how much food they wish to eat for one day from a vending machine. Volunteers will also spend one day fasting followed by a day self-selecting their food from the vending machine. Findings from this study will provide knowledge about a possible causal link between energy expenditure and eating behavior. This information may shed light on why many weight loss interventions that increase energy expenditure do not work as well as expected, and may eventually lead to new weight loss approaches and therapies.

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Phoenix, Arizona, United States, 85014
        • NIDDK, Phoenix

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 55 years (Adult)

Accepts Healthy Volunteers

No

Study Population

Residents of the metropolitan Phoenix area

Description

  • INCLUSION CRITERIA:
  • Premenopausal women and men <55 years of age
  • Body weight <204 kg (<450 pounds) and >= 36 kg (>= 80 pounds)
  • Stable weight (+/-5% within past 6 months) as determined by volunteer report
  • Healthy, as determined by medical history, physical examination, and laboratory tests

EXCLUSION CRITERIA:

  • Age <18 years
  • Weight greater than or equal to 204 kg (greater than or equal to 450 pounds, maximum weight of the iDXA machine as per manufacturer s manual), or weight <36 kg (<80 pounds, minimum weight allowed based on the NIH guidelines of blood drawing for research purposes)
  • Use of medications affecting metabolism and appetite in the last three months
  • Expresses unwillingness to consume all food given during the weight maintaining diet portions of the study (e.g., due to strict dietary restrictions including allergies or vegetarian or kosher diet)
  • Current use of tobacco products, marijuana, amphetamines, cocaine, or intravenous drug use
  • Current pregnancy, pregnancy within the past 6 months or lactation
  • History or clinical manifestation of:

    • Type 1 and Type 2 diabetes mellitus
    • History of surgery for the treatment of obesity
    • Endocrine disorders, such as Cushing s disease, pituitary disorders, and hypo and hyperthyroidism
    • Pulmonary disorders, including chronic obstructive pulmonary disease
    • Cardiovascular diseases, including coronary heart disease, heart failure, arrhythmias, and peripheral artery disease
    • High blood pressure by sitting blood pressure measurement using an appropriate cuff higher than 140/90 mmHg on two or more occasions, or current antihypertensive therapy
    • Liver disease, including cirrhosis, active hepatitis B or C, and AST or ALT greater than or equal to 2x normal
    • Gastrointestinal disease including Crohn s disease, ulcerative colitis, celiac disease or other malabsorptive disorders
    • Abnormal kidney function (eGFR <60 mL/min/1.73m(2))
    • Central nervous system disease, including previous history of cerebrovascular accidents, dementia, neurodegenerative disorders or history of severe head trauma
    • Cancer requiring treatment in the past five years, except for nonmelanoma skin cancers or cancers that have clearly been cured
    • Infectious disease such as active tuberculosis, HIV (by self report), chronic coccidiomycoses or other chronic infections that might influence EE and weight
    • Diagnosis of binge eating disorder, anorexia and major psychiatric disorders based upon the DSM-IV including depression, schizophrenia and psychosis, which may impact the ability of the participant to be in the respiratory chamber for 24 hour time periods
  • Chronic ethanol use (more than 3 drinks/day)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 1. Chamber at 24C, fixed diet
Chamber at room temperature (24C) with a fixed eucaloric diet
23.25 hours inside respiratory chamber with the temperature set to 24°C
A diet that matches the participant's caloric needs
Other Names:
  • Eucaloric diet
Experimental: 2. Chamber at 24C, ad libitum diet
Chamber at room temperature (24C) with an ad libitum diet (self-select how much food they wish to eat)
23.25 hours inside respiratory chamber with the temperature set to 24°C
Participants can eat as much as they want
Experimental: 3. Chamber at 19C, fixed diet
Chamber at cold temperature (16C) with a fixed eucaloric diet
A diet that matches the participant's caloric needs
Other Names:
  • Eucaloric diet
23.25 hours inside respiratory chamber with the temperature set to19°C
Experimental: 4. Chamber at 19C, ad libitum diet
Chamber at cold temperature (19C) with an ad libitum diet (self-select how much food they wish to eat)
Participants can eat as much as they want
23.25 hours inside respiratory chamber with the temperature set to19°C
Experimental: 5. Chamber at 24C, fasting
Chamber at room temperature (24C) fasting while in chamber and 12 hours before
23.25 hours inside respiratory chamber with the temperature set to 24°C
Participants do not eat for 12 hours before and 24 hours in chamber

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24-hour Energy Expenditure (kcal)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
Energy expenditure (EE) as measured during 24 hours in a whole-room calorimeter
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
24-hour Energy Intake (kcal)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
Energy intake as measured during 24 hours in a whole-room calorimeter
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
24- Hour Respiratory Quotient (RQ)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
RQ, an approximation for the ratio of carbohydrate-to-fat oxidation rates, is measured while in the chamber
Days 6 (Chamber at 24°C, fixed diet), 10(Chamber at 24°C, ad libitum diet), 14(Chamber at 19°C, fixed or ad libitum diet), 18(Chamber at 19°C, fixed or ad libitum diet), and 21(Chamber at 24°C, fasting)
Leptin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma leptin (ng/ml)
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Secretin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma secretin (ng/ml)
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Ghrelin
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma grehlin (pg/ml)
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
FGF-21
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Plasma FGF-21 (pg/ml)
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Core Body Temperature (C)
Time Frame: Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Core body temperature measured in chamber
Days 6 (Chamber at 24°C, fixed diet), 14(Chamber at 19°C, fixed diet) or 18(Chamber at 19°C, fixed diet), and 21(Chamber at 24°C, fasting)
Weight Change at 6 Months
Time Frame: 6 months
Weight change from baseline to 6 months
6 months
Weight Change at 12 Months
Time Frame: 12 months
Weight change from baseline to 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas Chang, M.D., National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 27, 2017

Primary Completion (Actual)

June 24, 2024

Study Completion (Actual)

June 24, 2024

Study Registration Dates

First Submitted

October 19, 2016

First Submitted That Met QC Criteria

October 19, 2016

First Posted (Estimated)

October 20, 2016

Study Record Updates

Last Update Posted (Actual)

July 4, 2025

Last Update Submitted That Met QC Criteria

June 23, 2025

Last Verified

July 3, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 999917004
  • 17-DK-N004 (Other Identifier: NIDDK)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Normal temperature

Subscribe